Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · IEX Real-Time Price · USD

1.740

-0.020 (-1.14%)

At close: Apr 19, 2024, 4:00 PM

1.730

-0.010 (-0.57%)

After-hours: Apr 19, 2024, 6:56 PM EDT

Xeris Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	67.45	121.97	67.27	37.6	19.52	45.72	42.05	32.27
Short-Term Investments	5	0	35.16	96.19	56.03	66.92	0	0
Cash & Cash Equivalents	72.45	121.97	102.43	133.79	75.55	112.63	42.05	32.27
Cash Growth	-40.60%	19.07%	-23.44%	77.09%	-32.92%	167.89%	30.30%	-
Receivables	39.2	30.83	17.46	6.88	4.69	2.87	1.2	0.1
Inventory	38.84	24.74	18.12	8.35	2.18	0	0	0
Other Current Assets	5.78	9.29	4.59	3.2	5.07	2.4	0.81	0.8
Total Current Assets	156.26	186.82	142.6	152.21	87.48	117.9	44.05	33.17
Property, Plant & Equipment	29.18	9.51	6.63	6.71	7.85	2.03	0.79	0.31
Long-Term Investments	0	0	0	0	13.23	0	0	0
Goodwill and Intangibles	132.62	143.47	154.31	0	0	0	0	0
Other Long-Term Assets	4.54	4.73	0.83	0.23	0.42	0.1	0.16	0.05
Total Long-Term Assets	166.34	157.7	161.77	6.94	21.5	2.13	0.95	0.36
Total Assets	322.6	344.52	304.36	159.15	108.99	120.03	45	33.53
Accounts Payable	11.57	4.61	8.92	3.12	5.6	0.87	1.98	1.32
Current Debt	3.5	1.58	0	0	0	0	0	0
Other Current Liabilities	80.13	67.44	70.12	25.09	21.74	9.31	2.88	1.21
Total Current Liabilities	95.19	73.62	79.04	28.21	27.34	10.17	4.86	2.53
Long-Term Debt	225.7	196.48	88.07	87.02	58.31	31.89	0	0
Other Long-Term Liabilities	8.5	29.24	42.02	10.16	8.91	2.56	0.09	0.04
Total Long-Term Liabilities	234.19	225.71	130.09	97.18	67.21	34.45	0.09	0.04
Total Liabilities	329.38	299.34	209.13	125.39	94.55	44.62	4.95	2.57
Total Debt	229.19	198.06	88.07	87.02	58.31	31.89	0	0
Debt Growth	15.72%	124.89%	1.20%	49.25%	82.83%	-	-	-
Retained Earnings	-617.03	-554.77	-460.11	-337.39	-246.25	-120.67	-60.59	-34.03
Comprehensive Income	-0.03	-0.02	-0.03	0.01	0.04	-0.05	0	0
Shareholders' Equity	-6.78	45.19	95.23	33.76	14.44	75.41	-57.83	-31.93
Net Cash / Debt	-156.74	-76.09	14.37	46.77	17.24	80.74	42.05	32.27
Net Cash / Debt Growth	-	-	-69.28%	171.21%	-78.64%	92.04%	30.30%	-
Net Cash Per Share	-1.14	-0.56	0.18	1.10	0.66	6.70	20.73	17.51
Working Capital	61.07	113.2	63.56	124.01	60.15	107.73	39.19	30.65
Book Value Per Share	-0.05	0.33	1.21	0.79	0.55	6.26	-28.51	-17.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).